Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLLS | AMGN | VRTX | REGN | GILD |
| Company | Cellectis S.A. ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.06 | 333.23 | 497.00 | 1,075.35 | 72.89 |
| High | 2.06 | 336.35 | 498.77 | 1,078.71 | 73.32 |
| Low | 2.05 | 332.63 | 492.00 | 1,066.22 | 72.02 |
| Last | 2.06 | 333.11 | 495.44 | 1,068.55 | 72.20 |
| Change | +0.03 | +1.82 | +3.87 | +4.95 | -0.36 |
| % Change | +1.54% | +0.55% | +0.79% | +0.47% | -0.50% |
| Volume | 1,684 | 162,126 | 134,275 | 34,023 | 448,074 |
| 20-Day Average Volume | 33,406 | 2,005,890 | 1,093,947 | 411,949 | 6,248,009 |
| Previous Close | 2.03 | 331.29 | 491.57 | 1,063.60 | 72.56 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.00 | 321.00 | 481.72 | 1,064.51 | 69.80 |
| 20-Day Raw Stochastic | 63.16% | 88.74% | 84.70% | 64.61% | 76.77% |
| 20-Day Relative Strength | 43.47% | 68.18% | 65.88% | 58.48% | 63.98% |
| Weighted Alpha | -57.19 | +41.68 | +42.86 | +42.88 | -4.00 |
| Today's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 64% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.44% since 07/15/24 | +1.55% since 07/15/24 | +0.29% since 07/15/24 | -0.87% since 07/15/24 | +2.88% since 07/15/24 |
| Low | 2.02 on 07/19/24 | 328.00 on 07/16/24 | 478.78 on 07/17/24 | 1,060.74 on 07/19/24 | 70.33 on 07/16/24 |
| High | 2.20 on 07/17/24 | 338.98 on 07/18/24 | 497.00 on 07/22/24 | 1,100.08 on 07/16/24 | 74.92 on 07/18/24 |
| 1-Month | |||||
| %Chg | +8.99% since 06/21/24 | +8.80% since 06/21/24 | +5.02% since 06/21/24 | +1.86% since 06/21/24 | +3.08% since 06/21/24 |
| Low | 1.82 on 06/27/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 66.01 on 07/05/24 |
| High | 2.20 on 07/17/24 | 338.98 on 07/18/24 | 497.00 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 3-Month | |||||
| %Chg | -21.97% since 04/22/24 | +23.31% since 04/22/24 | +23.09% since 04/22/24 | +19.17% since 04/22/24 | +8.81% since 04/22/24 |
| Low | 1.82 on 06/27/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 3.38 on 05/06/24 | 338.98 on 07/18/24 | 497.00 on 07/22/24 | 1,106.16 on 07/12/24 | 74.92 on 07/18/24 |
| 6-Month | |||||
| %Chg | -24.82% since 01/22/24 | +8.10% since 01/22/24 | +11.85% since 01/22/24 | +13.78% since 01/22/24 | -7.11% since 01/22/24 |
| Low | 1.82 on 06/27/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 3.38 on 05/06/24 | 338.98 on 07/18/24 | 497.00 on 07/22/24 | 1,106.16 on 07/12/24 | 81.06 on 01/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 112,836 | 177,715,552 | 126,851,120 | 117,193,824 | 90,399,088 |
| Shares Outstanding, K | 55,584 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 9,190,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -101,060,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 6,500,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | 5,640,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 3.10 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 05/28/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 32.41 | 28.76 | 18.24 |